Study provides MIS-C treatment guidance

(Louisiana State University Health Sciences Center) An analysis conducted by a group of investigators including Tamara Bradford, MD, Associate Professor of Pediatrics at LSU Health New Orleans School of Medicine, found that children and adolescents with Multisystem inflammatory syndrome in children (MIS-C) initially treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news